Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0204-2025

Drug recall · January 22, 2025

Cardura XL recall

Why: Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93

Lots / codes

Lot# 8182298, Exp 10/31/2025

Quantity
6,605/30 count bottles
Company
Viatris Inc, Canonsburg, PA
Distribution
USA nationwide.
Initiated
December 23, 2024 · Voluntary: Firm initiated
Classified
January 16, 2025
Reported
January 22, 2025
Ended
November 12, 2025
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Cardura

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.